Supporting Literature

The clinical efficacy of Dermacell AWM is supported by numerous peer-reviewed and published articles in its intended field of use. Dermacell AWM is part of the largest human ADM in chronic wound randomized controlled trial to date, as well as findings by other peer-reviewed and published articles.


Peer-Reviewed Publications 

Cazzell S, Vayser D, Pham H, Walters J, Reyzelman A, Samsell B, Dorsch K, Moore M. Wound Repair and Regeneration. 2017. 45:483-497.
Cazzell S. Wounds. 2019. 31(3):68-74.
Cazzell S, Moyer P, Samsell B, Dorsch K, McLean J, Moore M. Adv Skin Wound Care. 2019. 32(9):409-415.
Walters J, Cazzell S, Pham H, Vayser D, Reyzelman A. Eplasty. 2016. 16: e10.
Robb GL, Gurtner GC.  Eplasty. 2016; 16: e27.
Macrophage phenotypes correspond with remodeling outcomes of various acellular dermal matrices
Agrawal H, Tholpady SS, Capito AE, Drake DB, Katz AJ. Open Journal of Regenerative Medicine. 2012. 1(3): 51-59
Evaluation of host tissue integration, revascularization, and cellular infiltration within various dermal substrates
Capito AE, Tholpady SS, AgrawalH, Drake DB, Katz AJ. Annals of Plastic Surgery. 2012. 68(5): 495-500.
A comparison of human and porcine acellularized dermis: Interactions with human fibroblasts in vitro
Armour AD, Fish J, Woodhouse KA, Semple JL. Plastic and Reconstructive Surgery. 2006. 117(3): 845-856.

White Papers